Center of Uterine Cancer Diagnosis & Therapy Research of Zhejiang Province, Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, People's Republic of China.
Drug Des Devel Ther. 2021 Feb 15;15:577-588. doi: 10.2147/DDDT.S291865. eCollection 2021.
This study aimed to investigate the effects of quercetin on the efficacy of various chemotherapeutic drugs in cervical cancer cells.
All drug experiments were performed in HeLa and SiHa cells. The cell viability was detected by Cell Counting Kit-8 assay, and cell proliferation was estimated by bromodeoxyuridine assay. CompuSyn software was utilized to calculate the combination index (CI) and evaluate the synergistic or antagonistic effect of quercetin with cisplatin, paclitaxel, 5-fluorouracil and doxorubicin on cell viability. Cell migration and invasion abilities were detected by transwell assays, and cell apoptosis was measured by flow cytometry. The expression levels of matrix metallopeptidase 2 (MMP2), ezrin, P-glycoprotein (P-Gp) and methyltransferase-like 3 (METTL3) protein treated with various drugs were analyzed by Western blotting.
Quercetin inhibited the viability of HeLa and SiHa cells in a dose- and time-dependent manner. The CI values of quercetin with cisplatin, paclitaxel, 5-fluorouracil and doxorubicin were <1, >1, >1 and >1, respectively. The effect of combination of quercetin and cisplatin on cell proliferation was stronger than their individual effects. Co-treatment group could inhibit more cell migration and invasion in contrast to single-drug group. Besides, quercetin combined with cisplatin group induced more cell apoptosis in contrast to single-drug group. The results of Western blotting showed that the expression levels of MMP2, ezrin, P-Gp and METTL3 in co-treatment group were lower than in cisplatin group, respectively.
Quercetin and cisplatin had synergistic inhibitory effect on cervical cancer cells. Quercetin might enhance the antitumor effect of cisplatin via inhibiting proliferation, migration and invasion and elevating apoptosis through weakening MMP2, ezrin, METTL3 and P-Gp expression of cancer cells.
本研究旨在探讨槲皮素对宫颈癌细胞中各种化疗药物疗效的影响。
所有药物实验均在 HeLa 和 SiHa 细胞中进行。通过细胞计数试剂盒-8 检测细胞活力,通过溴脱氧尿苷测定法估计细胞增殖。利用 CompuSyn 软件计算联合指数(CI),并评估槲皮素与顺铂、紫杉醇、5-氟尿嘧啶和阿霉素对细胞活力的协同或拮抗作用。通过 Transwell 测定法检测细胞迁移和侵袭能力,通过流式细胞术检测细胞凋亡。用 Western blot 分析用各种药物处理后的基质金属蛋白酶 2(MMP2)、埃兹蛋白、P-糖蛋白(P-Gp)和甲基转移酶样 3(METTL3)蛋白的表达水平。
槲皮素呈剂量和时间依赖性抑制 HeLa 和 SiHa 细胞的活力。槲皮素与顺铂、紫杉醇、5-氟尿嘧啶和阿霉素的 CI 值分别<1、>1、>1和>1。槲皮素与顺铂联合用药对细胞增殖的影响强于其单独作用。与单药组相比,联合组能更有效地抑制细胞迁移和侵袭。此外,与单药组相比,槲皮素联合顺铂组诱导的细胞凋亡更多。Western blot 结果表明,与顺铂组相比,联合组中 MMP2、埃兹蛋白、P-Gp 和 METTL3 的表达水平分别降低。
槲皮素和顺铂对宫颈癌细胞具有协同抑制作用。槲皮素可能通过抑制增殖、迁移和侵袭,通过降低 MMP2、埃兹蛋白、METTL3 和 P-Gp 表达来增强顺铂的抗肿瘤作用。